# Independent adversarial review

Updated: 2026-10-09. Independent reviewer inspected implementation046287d plus working core/name/provenance changes, requirements and tests. One full review followed by targeted delta review; no repeated mandatory proof cycle.

Four actionable findings were reproduced and fixed with tests first:

| Finding | Fix and verification |
| --- | --- |
| P2 escalation diagnostics omitted classified intent/reason | Core records actual human/medical/unsupported turn intent and fixed escalation reason; unresolved identity/policy denial receive allowlisted categories. Review regressions pass. |
| P2 truncated model HTTP response escaped safe handling | OpenAI adapter catches HTTPException/IncompleteRead as model_unavailable, makes one attempt and emits no raw failure content. Controlled transport regressions pass. |
| P2 normalized policy facts not inspectable (FR022) | Core retains exact ten categorical inputs per decision; UI validates exact enum contract and renders safe snapshot. Invalid/extra/nested facts are omitted. Actual-core/privacy UI tests pass. |
| P3 invalid CLI API configuration raised traceback | CLI catches actual ApiError configuration failure, returns2 with safe message and no raw URL. Subprocess regression passes. |

Independent targeted delta review: all four findings closed,37focused tests passed in0.640s, no introduced defect found. Root combined verification separately recorded in [validation](../../../specs/001-appointment-scheduling/quickstart.md). Reviewer did not independently reproduce external live-model evidence or remote clone checks; those have separate receipts. No raw consultation transcript, secrets or patient data is included.

Enterprise authentication, durable idempotency, distributed effects, clinical governance and load proof remain explicit limitations rather than newly invented MVP review gates. Final source revision is recorded by the immutable completion checkpoint and as-built docs; a checkpoint does not certify production readiness.
